Table 2. Mean values of each anthropometric indicator according to metabolic parameters separated by gender.
Data are presented as mean ± Standard deviation (number of individuals).
| BMI | BAI | WHR | WC | WTR | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| M | F | M | F | M | F | M | F | M | F | |
| Cholesterol | ||||||||||
| Cho - | 24.9 ± 4.9 (118) | 26.0 ± 6.1 (92) | 24.9 ± 4.6 | 32.0 ± 6.2 | 0.94 ± 0.08 | 0.92 ± 0.08 | 90.9 ± 13.8 | 92.2 ± 15.0 | 1.73 ± 0.21 | 1.65 ± 0.20 |
| Cho+ | 25.8 ± 4.2 (42) | 28.9 ± 7.5* (28) | 24.7 ± 3.7 | 34.4 ± 7.8 | 0.99 ± 0.07* | 0.97 ± 0.09* | 95.6 ± 11.5 | 100.1 ± 14* | 1.83 ± 0.18* | 1.76 ± 0.19* |
| Triglycerides | ||||||||||
| Tri - | 24.2 ± 5.4 (76) | 26.1 ± 5.9 (75) | 25.0 ± 5.4 | 32.3 ±6.1 | 0.92 ± 0.08 | 0.91 ± 0.08 | 88.6 ± 15.1 | 92.3 ±14.5 | 1.70 ± 0.22 | 1.64 ± 0.21 |
| Tri+ | 25.8 ± 3.8* (84 | 27.6 ± 7.5 (45) | 24.7 ± 3.2 | 33.0 ± 7.6 | 0.98 ±0.07** | 0.96 ± 0.08* | 95.4 ± 10.7** | 97.0 ± 15.8 | 1.81 ± 0.17** | 1.73 ± 0.18* |
| HDL Cholesterol | ||||||||||
| HDL- | 25.6 ± 4.1(81) | 27.2 ± 6.6 (94) | 24.9 ± 3.8 | 32.9 ± 6.8 | 0.97 ± 0.08 | 0.94±0.08 | 94.0 ± 12.8 | 95.5 ± 14.7 | 1.78 ± 0.19 | 1.69 ± 0.20 |
| HDL+ | 24.5 ± 5.3(79) | 24.8 ± 6.3 (26) | 24.9 ± 5.0 | 31.4 ± 5.8 | 0.94 ± 0.08* | 0.89±0.09* | 90.2 ± 13.9* | 89.1 ± 15.8* | 1.74 ± 0.22 | 1.64 ± 0.22 |
| LDL Cholesterol | ||||||||||
| LDL- | 24.5 ± 4.4 (98) | 25.6 ± 6.1(77) | 24.7 ± 4.1 | 31.5 ± 6.1 | 0.94 ± 0.08 | 0.92 ± 0.09 | 89.9 ± 13.1 | 91.7 ± 15.1 | 1.73 ± 0.19 | 1.65 ± 0.22 |
| LDL+ | 26.0 ± 5.1 (62) | 28.6 ± 6.9 (43) | 25.1 ± 4.9 | 34.5 ± 7.2* | 0.98 ± 0.08 | 0.95 ± 0.08 | 95.7 ± 13.4* | 98.4 ± 14.2* | 1.81 ± 0.22* | 1.71 ± 0.18 |
| Fasting glycemia | ||||||||||
| Gly- | 24.5 ± 4.2 (101) | 5.8 ± 6.2 (84) | 24.8 ± 3.7 | 32.1 ± 6.3 | 0.94 ± 0.08 | 0.92 ± 0.09 | 89.9 ± 12.3 | 91.5 ± 14.7 | 1.71 ± 0.18 | 1.64 ± 0.20 |
| Gly+ | 26.1 ± 5.4 (59) | 28.8 ± 6.9* (36) | 24.9 ± 5.5 | 33.8 ± 7.3 | 0.98 ± 0.08* | 0.96 ± 0.07* | 96.0 ± 14.6* | 100.3 ± 14.5* | 1.83 ± 0.21** | 1.75 ± 0.20* |
| Metabolic syndrome | ||||||||||
| MS- | 22.8 ± 3.13 (82) | 23.8 ± 5.8 (52) | 23.7 ± 3.26 | 30.3 ± 5.9 | 0.91 ± 0.07 | 0.89 ± 0.08 | 84.8 ± 9.2 | 86.5 ± 14.4 | 1.67 ± 0.17 | 1.61 ± 0.22 |
| MS+ | 27.4 ± 5.0**(78) | 29.0 ± 6.2**(66) | 26.0 ±5.16* | 34.5 ±5.9** | 1.00 ± 0.07** | 0.96 ± 0.08** | 99.8 ± 12.9** | 100.4 ±12.6** | 1.86 ± 0.19** | 1.73 ± 0.17** |
BMI: body mass index; BAI: body adiposity index; WHR: waist to hip ratio;WC: waist to hip circumference; WTR: waist to thigh ratio; M: male; F: female; Cho- and Cho+: patients with total cholesterol lower and higher than 220 mg/dl, respectively; Tri- and Tri+: patients with triglycerides lower and higher than 150 mg/dl, respectively; HDL- and HDL+: patients with HDL cholesterol lower and higher than 40 mg/dl (male) and 50 mg/dl(female), respectively; LDL- and LDL+: patients with LDL cholesterol lower and higher than 130 mg/dl, respectively, gly- and gly+: patients with fasting glycemia lower and higher than 100 mg/dl, respectively; MS- and MS+: patients with or without metabolic syndrome according to The National Cholesterol Education Program III criteria, respectively.
* p<0.05;
**p<0.001 comparing groups—with + for each gender.